Increased serum midkine levels during hemodialysis using heparin in chronic renal failure

Journal of Biochemistry

Volumn 123, Issue 5, 1998, Pages 864-869

  Fujisawa, Kazuhiro ^a   Matsumoto, Yoshihiro ^a   Muramatsu, Hisako ^b   Shinzato, Toru ^a   Hiramatsu, Kenjyu ^b   Horie, Katunori ^a   Cai, Zhe ^a   Oka, Hirohumi ^c   Amano, Izumi ^d   Muramatsu, Takashi ^b   Maeda, Kenji ^a  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Meisei Clinic   (Japan)

^d Shakaihoken Chyukyo Hospital   (Japan)

Author keywords

Endothelial cells; Hemodialysis; Heparin; Midkine; Uremic complications

Indexed keywords

HEPARIN; MIDKINE;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HUMAN; MALE; UREMIA;

EID: 0031971179     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jbchem.a022017     Document Type: Article

References (42)

1. Kadomatsu, K., Tomomura, M., and Muramatsu, T. (1988) cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mild-gestation period of mouse embryogenesis. Biochem. Biophys. Res. Commun. 151, 1312-1318
2. Li, Y., Milner, P., Chauhan, A., Watson, M., Hoffman, R., Kodner, C., Milbrandt, J., and Deuel, T. (1990) Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science 250, 1690-1694
3. Tsutsui, J., Kadomatsu, K., Matsubara, S., Nakagawara, A., Hamanoue, M., Takao, S., Shimazu, H., Ohi, Y., and Muramatsu, T. (1993) A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. Cancer Res. 53, 1281-1285
4. Chauhan, A.K., Li, Y.S., and Deuel, T.F. (1993) Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice. Proc. Natl. Acad. Sci. USA 90, 679-682
5. Choudhuri, R., Zhang, H.T., Donnini, S., Ziche, M., and Bicknell, R. (1997) An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res. 57, 1814-1819
6. Nakanishi, T., Kadomatsu, K., Okamoto, T., Ichihara-Tanaka, K., Kojima, T., Saito, H., Tomoda, Y., and Muramatsu, T. (1997) Expression of syndecan-1 and -3 during embryogenesis of the central nervous system in relation to binding with midkine. J. Biochem. 121, 197-205
7. Fu, C., Maminta-Smith, L.D., Guo, C., and Deuel, T.F. (1994) Cloning and sequence of the Xenopus laevis homologue of the midkine cDNA. Gene 146, 311-312
8. Tsutsui, J., Uehara, K., Kadomatsu, K., Matsubara, S., and Muramatsu, T. (1991) A new family of heparin-binding factors: strong conservation of midkine sequences between the human and the mouse. Biochem. Biophys. Res. Commun. 176, 792-797
9. Nakagawara, A., Mibrandt, J., Muramatsu, T., Deuel, T.F., Zhao, H., Cnaan, A., and Brodeur, G.M. (1995) Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res. 55, 1792-1797
10. Garver, R.J., Radford, D.M., Donis, K.H., Wick, M.R., and Milner, P.G. (1994) Midkine and pleiotrophin expression in normal and malignant breast tissue. Cancer (Phila.) 74, 1584-1590
11. Muramatsu, H., Song, X.J., Koide, N., Hada, H., Tsuji, T., Kadomatsu, K., Inui, T., Kimura, T., Sakakibara, S., and Muramatsu, T. (1996) Enzyme-linked immunoassay for midkine, and its application to evaluation of midkine levels in developing mouse brain and sera from patients with hepatocellular carcinomas. J. Biochem. 119, 1171-1175
12. O'Brien, T., Cranston, D., Fuggle, S.M., Bicknell, R., and Harris, A.L. (1996) The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers. Cancer Res. 56, 2515-2518
13. Yasuhara, O., Muramatsu, H., Kim, S.U., Muramatsu, T., Maruta, H., and McGeer, P.L. (1993) Midkine, a novel neurotrophic factor, is present in senile plaques of alzheimer disease. Biochem. Biophys. Res. Commun. 192, 246-251
14. Yoshida, Y., Goto, M., Tsutsui, J., Ozawa, M., Sato, E., Osame, M., and Muramatsu, T. (1995) Midkine is present in the early stage of cerebral infarct. Dev. Brain Res. 85, 25-30
15. Takada, T., Toriyama, K., Muramatsu, H., Song, X.J., Torii, S., and Muramatsu, T. (1997) Midkine, a retinoic acid-inducible heparin-binding cytokine, is a key molecule regulating the inflammatory responses: chemotactic activity to neutrophils and association with inflammatory synovitis. J. Biochem. 122, 453-458
16. Hiramatsu, K., Yoshida, H., Kimura, T., and Takagi, K. (1998) Midkine induces histamine release from mast cells and the immediate cutaneous response. Biochem. Mol. Biol. Int. 44, 453-462
17. Nissenson, A.R., Nimer, S.D., and Wolcott, D.L. (1991) Recombinant human erythropoietin and renal anemia: molecular biology, clinical efficacy, and nervous system effects. Ann. Intern. Med. 114, 402-416
18. Hory, B. and Drueke, T.B. (1997) The parathyroid-bone axis in uremia: new insights into old questions. Curr. Opin. Nephrol. Hypertens. 6, 40-48
19. 2-Microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis-associated amyloidosis. Biochem. Biophys. Res. Commun. 201, 1235-1241
20. 2-microglobulin modified with advanced glycation end products. Kidney Int. 49, 538-550
21. Inui, T., Bodi, J., Kubo, S., Nishio, H., Kimura, T., Kojima, S., Maruta, H., Muramatsu, T., and Sakakibara, S. (1996) Solution synthesis of human midkine, a novel heparin binding neurotrophic factor consisting of 121 amino acid residues with five disulfide bonds. J. Pept. Sci. 2, 28-39
22. Muramatsu, H. and Muramatsu, T. (1991) Purification of recombinant midkine and examination of its biological activities: functional comparison of new heparin binding factors. Biochem. Biophys. Res. Commun. 177, 652-658
23. Muramatsu, H., Shirahama, H., Yonezawa, S., Maruta, H., and Muramatsu, T. (1993) Midkine, a retinoic acid-inducible growth/ differentiation factor: Immunochemical evidence for the function and distribution. Dev. Biol. 159, 392-402
24. Kino, K., Akizawa, T., and Koshikawa, S. (1995) Effects of membrane characteristics on cytokine production by mononuclear cells in regular haemodialysis patients. Nephrol. Dial. Transplant. 10, Suppl 3, 29-33
25. Pereira, B.J., Snodgrass, B., Barber, G., Perella, C., Chopra, S., and King, A.J. (1995) Cytokine production during in vitro hemodialysis with new and formaldehyde- or renalin-reprocessed cellulose dialyzers. J. Am. Soc. Nephrol. 6, 1304-1308
26. Shaldon, S. and Koch, K.M. (1995) Biocompatibility in hemmodialysis: clinical relevance in 1995. Artif. Organs 19, 395-397
27. Hahn, P.F. (1943) Abolishment of alimentary lipemia following injection of heparin. Science 98, 19-20
28. Karlsson, K. and Marklund, S.L. (1987) Heparin-induced release of extracellular superoxide dismutase to human blood plasma. Biochem. J. 242, 55-59
29. Kojima, S., Muramatsu, H., Amanuma, H., and Muramatsu, T. (1995) Midkine enhances fibrinolytic activity of bovine endothelial cells. J. Biol. Chem. 270, 9590-9596
30. Dano, K., Andreasen, P.A., Grondahl-Hansen, J., Kristensen, P., Nielsen, L.S., and Skriver, L. (1985) Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res. 44, 139-266
31. Markus, G. (1988) The relevance of plasminogen activators to neoplastic growth. A review of recent literature. Enzyme 40, 158-172
32. Hasui, Y., Marutsuka, K., Nishi, S., Kitada, S., Osada, Y., and Sumiyoshi, A. (1994) The content of urokinase-type plasminogen activator and tumor recurrence in superficial bladder cancer. J. Urol. 151, 16-20
33. Matas, A.J., Simmons, R.L., Kjellstrand, C.M., Buselmeier, T.J., and Najarian, J.S. (1975) Increased incidence of malignancy during chronic renal failure. Lancet 1, 883-886
34. Riambou, E., Roma, J., Aubia, J., Lioveras, J., and Masramon, J. (1987) Malignant disorders and long-term survival in haemodialysis patients. Lancet 1, 754-755
35. 2-Microglobulin amyloidosis and renal bone disease. Miner. Electrolyte Metab. 17, 261-272
36. Depierreux, M., Goldman, M., Fayt, I., Richard, C., Quintin, J., Dhaene, M., and Van Herweghem, J.L. (1988) Osteoarticular amyloidosis associated with haemodialysis: an immunoultrastructural study. J. Clin. Pathol. 41, 158-162
37. 2-microglobulin type: a complication of long term haemodialysis. J. Clin. Pathol. 40, 1247-1251
38. De Marchi, S., Cecchin, E., Villalta, D., Sepiacci, G., Santini, G., and Bartoli, E. (1992) Relief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremia. N. Eng. J. Med. 326, 969-974
39. Stockenhuber, P., Sunder-Plassmann, G., and Balcke, P. (1987) Increased plasma histamine levels in chronic renal failure. N. Eng. J. Med. 317, 386
40. Stockenhuber, F., Kurz, R.W., Sertl, K., Grimm, G., and Balcke, P. (1990) Increased plasma histamine levels in uraemic pruritus. Clin. Sci. 79, 477-482
41. Qian, J., Yu, Z., Dai, H., Zhang, Q., and Chen, S. (1995) Influence of hemodialysis membranes on gene expression and plasma levels of interleukin-1β. Artif. Organs 19, 842-846
42. Lin, Y.F., Chang, D.M., Shaio, M.F., Lu, K.C., Chyr, S.H., Li, B.L., and Sheih, S.D. (1996) Cytokine production during hemodialysis: effects of dialytic membrane and complement activation. Am. J. Nephrol. 16, 293-299